What is Elranatamab: Uses, Dosage, Side Effects and More

Elranatamab is a breakthrough cancer treatment specifically designed to help people with multiple myeloma, a type of blood cancer that affects plasma cells in your bone marrow. This medication works like a smart bridge, connecting your body's immune system directly to cancer cells so your natural defenses can fight the disease more effectively.

You might feel overwhelmed learning about a new cancer treatment, and that's completely understandable. This medication represents hope for people whose multiple myeloma has returned or hasn't responded to other treatments, offering a targeted approach that can help your body take control of the fight against cancer.

What is Elranatamab?

Elranatamab is an immunotherapy drug that belongs to a class called bispecific T-cell engagers. Think of it as a specialized connector that helps your immune system recognize and attack multiple myeloma cells more effectively than it could on its own.

The medication is given as an injection under your skin, similar to how people with diabetes take insulin. This subcutaneous method means you won't need lengthy hospital visits for IV infusions, making treatment more convenient and comfortable for you.

Your doctor will typically consider this treatment when other multiple myeloma therapies haven't worked well enough or when the cancer has returned after previous treatments. It's specifically approved for adults whose disease has been resistant to other standard treatments.

What is Elranatamab Used For?

Elranatamab treats relapsed or refractory multiple myeloma in adults who have already tried at least four other treatment approaches. Multiple myeloma is a cancer where abnormal plasma cells grow uncontrollably in your bone marrow, crowding out healthy blood cells.

Your healthcare team will recommend this medication when your multiple myeloma has either come back after treatment or hasn't responded adequately to previous therapies. The drug is particularly valuable for people whose cancer has developed resistance to common multiple myeloma treatments like immunomodulatory drugs, proteasome inhibitors, and anti-CD38 antibodies.

This treatment offers hope when other options have been exhausted, giving you and your medical team another powerful tool to fight the disease. Many patients find comfort knowing they have access to this advanced therapy when facing challenging treatment situations.

How Does Elranatamab Work?

Elranatamab works by acting as a bridge between your immune system's T-cells and the cancer cells in your body. This medication is considered a strong, targeted therapy that specifically focuses on multiple myeloma cells while trying to preserve healthy tissue.

The drug attaches to two different proteins at once - one found on cancer cells called BCMA and another on your T-cells called CD3. When these connections form, your T-cells receive a powerful signal to attack and destroy the cancer cells directly.

This process essentially turns your own immune system into a more effective cancer-fighting force. Your body begins producing activated T-cells that can seek out and eliminate multiple myeloma cells throughout your system, potentially reaching cancer cells that other treatments might miss.

The medication continues working in your system for several days after each injection, giving your immune system sustained support in the fight against cancer. This ongoing action helps maintain pressure on the cancer cells between treatment doses.

How Should I Take Elranatamab?

Elranatamab is given as an injection under your skin, typically in your thigh, upper arm, or abdomen area. Your healthcare provider will show you or a caregiver how to give these injections safely at home, though initial doses are usually given in a medical facility.

You'll start with a step-up dosing schedule, which means your first few doses will be smaller amounts given over several days. This gradual approach helps your body adjust to the medication and reduces the risk of serious side effects.

Most people don't need to eat special foods before taking elranatamab, but you should stay well-hydrated by drinking plenty of water. Your doctor might recommend taking medications before your injection to help prevent side effects like fever or chills.

The injection sites should be rotated each time to prevent irritation. Clean the injection area with alcohol before each dose, and never inject into areas where your skin is tender, bruised, or irritated.

How Long Should I Take Elranatamab For?

You'll typically continue taking elranatamab for as long as it's helping control your multiple myeloma and you're tolerating the treatment well. Most people take this medication for many months, and some may need it for years.

Your doctor will monitor your response through regular blood tests and imaging scans to see how well the treatment is working. These appointments help determine whether you should continue, adjust the dose, or consider other treatment options.

Some people may need to take breaks from treatment if side effects become too challenging to manage. Your healthcare team will work with you to find the right balance between fighting the cancer and maintaining your quality of life.

The decision to stop elranatamab usually depends on several factors, including how your cancer is responding, what side effects you're experiencing, and your overall health status. Your doctor will guide you through this decision-making process when the time comes.

What Are the Side Effects of Elranatamab?

Elranatamab can cause side effects because it activates your immune system, which sometimes leads to inflammation throughout your body. Most people experience some side effects, but many are manageable with proper medical support and monitoring.

Common side effects that many people experience include fatigue, fever, chills, nausea, and decreased appetite. You might also notice changes in your blood counts, which can make you more susceptible to infections or cause you to feel more tired than usual.

Here are the most frequently reported side effects you should be aware of:

• Injection site reactions like redness, swelling, or tenderness
• Fever and chills, especially after the first few doses
• Fatigue and weakness that may last several days
• Nausea, vomiting, or decreased appetite
• Diarrhea or stomach discomfort
• Headaches or dizziness
• Muscle or joint pain
• Changes in blood pressure

These common side effects usually improve as your body adjusts to the treatment, and your healthcare team can provide medications to help manage them effectively.

More serious side effects can occur, though they're less common. The most concerning is cytokine release syndrome, which happens when your immune system becomes overactive and releases too many inflammatory substances at once.

Serious side effects that require immediate medical attention include:

• Severe fever over 101°F with chills or shaking
• Difficulty breathing or shortness of breath
• Rapid heartbeat or chest pain
• Severe nausea, vomiting, or diarrhea
• Signs of serious infection like persistent fever
• Neurological symptoms like confusion or seizures
• Severe skin reactions or widespread rash
• Unusual bleeding or bruising

Your doctor will monitor you closely, especially during the first few treatments, to catch any serious reactions early and provide appropriate treatment if needed.

Who Should Not Take Elranatamab?

Elranatamab isn't suitable for everyone, particularly people with certain medical conditions or those taking specific medications. Your doctor will carefully review your medical history before recommending this treatment.

You should not take elranatamab if you have a known allergy to the medication or any of its components. People with active, serious infections should wait until the infection is fully treated before starting this therapy.

Your healthcare provider will be especially cautious if you have any of these conditions:

• Current serious infections or a history of recurring infections
• Autoimmune diseases that affect your immune system
• Severe heart, lung, or liver problems
• History of severe allergic reactions to other medications
• Recent live vaccines or plans to receive them
• Pregnancy or plans to become pregnant
• Breastfeeding or plans to breastfeed

Women who could become pregnant need to use effective birth control during treatment and for several months after stopping elranatamab. The medication could harm an unborn baby, so family planning discussions with your doctor are important.

Your doctor will also consider your overall health status, other medications you're taking, and how well your bone marrow is functioning before recommending this treatment.

Elranatamab Brand Name

Elranatamab is sold under the brand name Elrexfio. This is the commercial name you'll see on your medication packaging and prescription labels.

When talking with your healthcare team or pharmacist, you can refer to your medication as either elranatamab or Elrexfio - both names refer to the same drug. Your insurance company and medical records will likely use both names interchangeably.

The medication comes in pre-filled syringes or vials, depending on your specific dosing needs. Your healthcare provider will determine which formulation works best for your treatment plan.

Elranatamab Alternatives

Several other treatments are available for relapsed or refractory multiple myeloma, though each works differently and may be appropriate for different situations. Your doctor will help you understand which options might work best for your specific case.

Other immunotherapy options include CAR-T cell therapy, where your own immune cells are modified in a laboratory to better fight cancer cells. There are also other bispecific antibodies like teclistamab that work similarly to elranatamab but target different proteins.

Alternative treatment approaches your doctor might consider include:

• CAR-T cell therapy for eligible patients
• Other bispecific antibodies like teclistamab
• Antibody-drug conjugates such as belantamab mafodotin
• Newer combination therapies with different drug classes
• Clinical trials testing experimental treatments
• Supportive care focused on managing symptoms

The best alternative depends on your previous treatments, overall health, and personal preferences. Your oncology team will work with you to explore all available options and find the approach that offers the best chance of success.

Is Elranatamab Better Than Teclistamab?

Both elranatamab and teclistamab are effective bispecific antibodies for treating multiple myeloma, but they work slightly differently and may be better suited for different patients. Neither is universally "better" than the other - the choice depends on your individual medical situation.

Elranatamab targets the BCMA protein on cancer cells, while teclistamab targets a different protein called GPRC5D. Both medications help your immune system attack cancer cells, but they may work better for different people depending on which proteins their cancer cells express.

Your doctor will consider several factors when choosing between these treatments, including your previous therapies, current health status, and the specific characteristics of your cancer cells. Some people may respond better to one medication over the other.

The side effect profiles are similar between both drugs, though individual people may tolerate one better than the other. Your healthcare team will monitor your response and adjust treatment as needed to find what works best for you.